To determine the efficacy of heparinized saline administered as intermittent flush on functional duration of the peripheral intravenous catheter (PIVC) in neonates. A total of 120 neonates were ...
Show More From the Department of PediatricsMedical College of Wisconsin, Children’s Hospital of Wisconsin, Milwaukee, WI; and DeVos Children’s Hospital, Grand Rapids, MI. PURPOSE: To determine whether ...
DefenCath is intended for instillation into central venous catheters only. DefenCath ® (taurolidine and heparin) catheter lock solution is now available for inpatient use to reduce the incidence of ...
The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...
This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...
MUNDELEIN, Ill.--(BUSINESS WIRE)--Medline Industries, Inc. and ICU Medical jointly purchased Excelsior Medical, a leading manufacturer of pre-filled saline and heparin flush syringes, syringe pumps ...
SHANGHAI/CHICAGO (Reuters) - Health agencies are investigating an outbreak of bloodstream infections in children from four U.S. states that may be linked to heparin and saline syringes made by Becton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback